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ABSTRACT
Isolates of 24 enterococci, 5 Enterococcus casseliflavus and 19 Enterococcus gallinarum, possessing 
vanC genes and showing low-level resistance to vancomycin were obtained from mice 
from commercial mouse breeding companies. Since some of these isolates showed 
resistance to other antibiotics, the purpose of this study was to clarify the resistant profiles 
of these isolates. One E. casseliflavus isolate showed resistance to erythromycin with a 
minimal inhibitory concentration (MIC) of 8 μg/mL and also showed apparent resistance 
to fluoroquinolones with an MIC of 32 μg/mL for ciprofloxacin. The MICs of 2 other 
fluoroquinolone-resistant E. casseliflavus and E. gallinarum isolates were 3 and 6 μg/mL, 
respectively. These 3 resistant isolates showed an absence of macrolide- and fluoroquinolone-
resistant genes, including amino acid substitutions in the quinolone resistance determining 
regions of DNA gyrase and topoisomerase IV. Resistance to tetracycline was detected in 
2 E. gallinarum isolates that were highly resistant, exhibiting MICs of 48 and 64 μg/mL and 
possessing tet(O) genes. The results indicate that antibiotic-resistant enterococci are being 
maintained in some laboratory mouse strains that have never been treated with an antibiotic.
Keywords: Antibiotic resistance; Enterococcus; laboratory mice
INTRODUCTION
Enterococcus spp. colonizing the intestinal tract of humans and animals comprise an essential 
part of the microbiota and are recognized as important opportunistic pathogens causing 
nosocomial infections of the urinary tract, endocarditis, bacteremia, and central nervous 
system infections [1,2]. Related to the use of glycopeptides in humans and livestock as 
medicines or growth promoters, in addition to intrinsic resistance to a number of antibiotics 
such as β-lactams and aminoglycosides, enterococci detected in humans and livestock 
have shown antibiotic resistance resulting from mutation or acquisition of foreign genetic 
material. The latter includes the transfer of the vancomycin-resistant gene via plasmids 
and transposons [3,4]. Therefore, the emergence of drug-resistant enterococci has been 
monitored not only in hospitals and clinics but also in the community [5].
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Antibiotics have not been administered to laboratory mice and rats by breeding companies 
for an extended period, resulting in a low incidence of drug resistance in such populations. 
Furthermore, no correlation has been found between the emergence of drug resistance 
in laboratory animals and those in humans or livestock [6]. However, detection of drug-
resistant Enterococcus faecalis and Enterococcus faecium that show resistance to tetracycline (TE) 
or erythromycin (E) in addition to β-lactams and aminoglycosides has been reported in 
laboratory mice and rats [7-9]. Recently, antibiotics have been used to control bacterial 
infections such as Rodentibacter species (“Pasteurella pneumotropica”) in laboratory animals in the 
animal facilities of academic institutions [10,11]. Therefore, monitoring for the emergence of 
antibiotic-resistant bacteria including Enterococcus spp. in laboratory animals may be required 
in laboratory animal facilities.
Our previous study showed that low-level vancomycin-resistant Enterococcus spp. (VRE; 5 
Enterococcus casseliflavus and 19 Enterococcus gallinarum isolates possessing vanC2/3 and vanC1 genes, 
respectively) were frequently detected in laboratory mice, including immunodeficient strains, 
obtained from commercial mouse breeding companies in Japan [12]. Our previous study also 
indicated that some of these VRE isolates showed resistance to other antibiotics, such as 
E, ciprofloxacin (CIP), or TE. In the present study, the drug sensitivities of these previously 
identified VRE isolates against the antibiotics are investigated in detail, and the related resistant 
genes partially identified. The results provide information on the antibiotic resistance profiles, 
other than their intrinsic resistances, of enterococci isolated in laboratory mice.
MATERIALS AND METHODS
VRE isolates from laboratory mice and Enterococcus type strains
VRE were isolated from fresh feces of laboratory mice supplied from 4 different commercial 
breeding companies between October 2011 and February 2012. Twenty-four isolates were 
identified (5 E. casseliflavus and 19 E. gallinarum) as reported previously [12] and as summarized 
in Table 1. These isolates possessed the vanC2/3 and vanC1 vancomycin-resistant genes, 
respectively, and exhibited low-level resistance to vancomycin with minimal inhibitory 
concentration (MIC) levels of no more than 12 μg/mL. The E. faecalis ATCC 29212 (JCM 7783), 
E. casseliflavus ATCC 25788 (JCM 8723), and E. gallinarum ATCC 49573 (JCM 8728) provided by 
the Japan Collection of Microorganisms (RIKEN BRC, Japan), which is participating in the 
National BioResource Project of the MEXT, Japan, were used as controls.
Antibiotic susceptibility
Antibiotic susceptibilities to E 15, CIP 5, norfloxacin 10 (NOR 10), TE 30, minocycline 30 
(MI 30), and doxycycline 30 (DX 30) were examined by using Sensi-Disc disc diffusion 
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Table 1. Isolates of low-level vancomycin resistant Enterococcus species and type strain used in this study
Source (No. mouse strain) Species No. isolates
Company 1 (5) E. casseliflavus 2
E. gallinarum 5
Company 2 (2) E. casseliflavus 2
E. gallinarum 2
Company 3 (5) E. gallinarum 5






testing (Becton Dickinson, USA). The MICs for E, CIP, and TE for each Enterococcus isolate 
were determined by using the E-test (bioMérieux, France). These tests were performed as 
described previously [12]. Briefly, bacterial suspensions in phosphate-buffered saline were 
adjusted to a turbidity of 0.5 McFarland standard, spread onto Mueller-Hinton agar (NISSUI, 
Japan), and incubated for 24−48 h at 37°C under aerobic conditions. After incubation, the 
sensitivities were graded as sensitive, intermediate or resistant based on measurement of the 
diameter of the inhibition zone. MICs were derived based on where the edge of the inhibition 
ellipse area intersected the test strip.
Sequencing analysis of the quinolone resistance-determining region (QRDR)
In order to detect mutations within the QRDR in 2 subunits of both DNA gyrase (gyrA and 
gyrB) and topoisomerase IV (parC and parE), polymerase chain reaction (PCR) and sequencing 
analysis were performed using the specific primer pairs summarized in Table 2. Briefly, after 
amplification of the QRDR by PCR, the PCR products were cloned into pCR 2.1-TOPO vectors 
(Invitrogen, USA) and introduced into Escherichia coli DH5α cells. Sequencing analysis of the 
QRDR from purified plasmids of competent cells was performed by using ABI PRISM BigDye 
Terminator v3.1 Cycle Sequencing Kits (Applied Biosystems, USA).
Detection of antibiotic-resistant genes
Macrolide- [13,14], fluoroquinolone- [15-17], TE- [14,18], and multidrug- [19-21] resistant 
genes and transposon integrase genes [14] were detected by PCR using specific primers 
for each reference cited, as summarized in Table 3. All reactions were performed in a final 
reaction volume of 20 μL with bacterial cells as a template, as well as 10 μL of EmeraldAmp 
PCR Master Mix (Takara Bio, Japan), and 1 μM of each primer. The PCR reactions were 
performed as described in each cited reference, and products were visualized on 1.5% agarose 
gels. Positive and suspicious PCR products were sequenced using each specific primer pair 
and were verified by comparison to other sequences in the National Center for Biotechnology 
Information database (https://blast.ncbi.nlm.nih.gov/Blast.cgi).
RESULTS
E-resistant VRE isolates from laboratory mice
All 19 E. gallinarum isolates and type strain E. gallinarum ATCC 49573 were sensitive to E. 
Although the type strain of E. casseliflavus (ATCC 25788) showed intermediate resistance to 
E, 1 of the 5 E. casseliflavus isolates indicated E resistance at a MIC of 8 μg/mL (Table 4). This 
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Table 2. Primers used to amplify the QRDR of Enterococcus isolates and analyze sequence
Species Name of gene Sequence of primer
E. casseliflavus gyrA F: 5′-TCAAGACGTCAATCTGACCA-3′
R: 5′-TACTCATACGTGCTTCGGTA-3′
E. gallinarum gyrA F: 5′-CCTCATAAAAAATCAGC-3′
R: 5′-AGAGATTAGGAAAACGA-3′










QRDR, quinolone resistance-determining region.
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E-resistant VRE isolate was detected in 1 of the 2 tested mouse strains supplied by company 
2, and this isolate also indicated resistance to fluoroquinolones as described below. The 
macrolide-resistant genes ermA, ermB, ermC, msrA/B, msrA, msrC, mefA/E, ereA, ereB, and mphA, 
and multidrug-resistant genes acrB, emeA, norA, norB, norC, and mepA (summarized in Table 3) 
were not detected in this E. casseliflavus isolate (Table 4). In addition, the transposon integrase 
gene (int) associated with the transfer of macrolide-resistant genes was not detected in the E. 
casseliflavus E-resistant isolate.
Fluoroquinolone-resistant VRE isolates from laboratory mice
The susceptibility of all 24 enterococcal isolates and the 2 type strains to the fluoroquinolone 
antibiotics CIP and NOR was between intermediate and resistant based on Sensi-Disc test 
scores. The MICs of all isolates for CIP were determined and 2 isolates, 1 each of E. casseliflavus 
and E. gallinarum, had MICs of 32 and 6 μg/mL, respectively, indicative of apparent resistance 
(Table 4). The E. casseliflavus isolate showing apparent resistance to fluoroquinolones also 
indicated resistance to E as described above. The MIC of the other E. casseliflavus isolate 
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Table 3. PCR detection of antimicrobial resistance and transposon integrase genes in this study
Antimicrobial class Mechanism of resistance Genes References
Macrolides Prevention of binding to ribosome ermA, ermB, ermC [14]
Efflux pump msrA/B, msrA, msrC [14]
mefA/E [13]
Enzymatic inactivation ereA, ereB, mphA [13]
Fluoroquinolones (PMQR) Blocking the action qnrA, qnrB, qnrS [15]
Enzymatic inactivation aac6′-Ib [17]
Efflux pump oqxA, oqxB [16]
qepA [17]




Efflux pump tet(K), tet(L) [14]
Multidrug Efflux pump acrB [21]
emeA [19]
norA, norB, norC, mepA [20]
Tn916-Tn1545 family Transposon integrase int [14]
PCR, polymerase chain reaction; PMQR, plasmid-mediated quinolone resistance; TE, tetracycline.
Table 4. Summary of antimicrobial resistance profiles of VRE isolates from laboratory mice
Species of isolates (source, mouse strain) Susceptibility* Gene for 
resistance
Susceptibility* Gene for resistance 
(including QRDR)







E. casseliflavs R NI R/R NI S/S/S -
(company 2, ddY) (8 µg/mL: R) (32 µg/mL: R) (2 µg/mL: S)
E. casseliflavus I - R/R NI S/S/S -
(company 2, BALB/c) (2 µg/mL: I) (3 µg/mL: I) (2 µg/mL: S)
E. gallinarum S - I/I - R/I/I tet(O)
(company 2, BALB/c) (0.38 µg/mL: S) (3 µg/mL: I) (48 µg/mL: R)
E. gallinarum I - R/R NI S/S/S -
(company 4, C57BL/6N) (0.75 µg/mL: I) (6 µg/mL: R) (3 µg/mL: S)
E. gallinarum S - I/I - R/I/I tet(O)
(company 4, BALB/c) (0.38 µg/mL: S) (2 µg/mL: I) (64 µg/mL: R)
E. casseliflavus ATCC25788 I - I/I - S/S/S -
(2 µg/mL: I) (2 µg/mL: I) (1.5 µg/mL: S)
E. gallinarum ATCC49573 S - S/S - R/R/I tet(S)
(0.38 µg/mL: S) (0.75 µg/mL: S) (96 µg/mL: R)
E, erythromycin; CIP, ciprofloxacin; NOR, norfloxacin; TE, tetracycline; MI, minocycline; DX, doxycycline; MIC, minimal inhibitory concentration for each antibiotics; 
S, sensitive; I, intermediate; R, resistant; NI, not identified; QRDR, quinolone resistance-determining region.
*The upper and lower lines were represented as the results of Sensi-Disc and MIC tests, respectively.
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scored as resistant by Sensi-Disc was ≤ 3 μg/mL indicating intermediate resistance to CIP. 
The 2 apparent resistant and 1 intermediate resistant isolates were obtained from different 
mouse strains supplied by company 2 and company 4 (Table 4). To clarify the mechanism 
of resistance to fluoroquinolones, the amino acid (AA) sequences of the QRDR of these 3 
isolates at positions 69−110 AA of gyrA, 415−460 AA of gyrB, 58−106 AA of parC, and 421−470 
AA of parE, which correspond to the AA positions of E. faecalis V583 (accession# AE016830), 
were analyzed and compared with those of each type strain and the sensitive isolates. 
However, no AA substitutions were detected in the QRDR of the 3 fluoroquinolone-resistant 
isolates. In addition, the plasmid-mediated quinolone resistance (PMQR) determinant 
genes qnrA, qnrB, qnrS, aac6’-Ib, oqxA, oqxB, and qepA, and the multidrug-resistant genes 
acrB, emeA, norA, norB, norC, and mepA (summarized in Table 3) were not detected in these 3 
fluoroquinolone-resistant VRE isolates (Table 4).
TE-resistant VRE isolates from laboratory mice
All 24 isolates were tested for resistance to the TE antibiotics TE, MI, and DX, by using 
Sensi-Disc discs. Two of the 24 VRE isolates, both E. gallinarum, indicated resistance to TE 
and intermediate resistance to MI and DX, while the type strain showed resistance to both TE 
and MI. One of the 2 TE-resistant E. gallinarum isolates was obtained from mice supplied by 
company 2 while the other was from company 4. Neither isolate was resistant to macrolides 
or fluoroquinolones (Table 4). The MICs for TE of the 2 isolates were 48 and 64 μg/mL and 
the MIC for the E. gallinarum type strain was 96 μg/mL, indicating high-level resistance. To 
identify the TE-resistant gene, tet genes and the multidrug-resistant genes acrB, emeA, norA, 
norB, norC, and mepA (summarized in Table 3) underwent PCR in the TE-resistant E. gallinarum 
isolates and the resistant E. gallinarum type strain. Although multidrug-resistant genes were 
not detected, tet(O) and tet(S) genes were identified in the 2 TE-resistant isolates and the type 
strain, respectively (Table 4). The detected tet(O) gene fragment, approximately 720−730 base 
pairs (bp), in the 2 isolates, showed 99% sequence identity with those of E. faecalis (GenBank 
accession No. NG048262 and AY660532), Actinobacillus spp. (NG048264), Streptococcus spp. 
(LC131132, FR691055, and NG048265), Campylobacter spp. (JQ613156 and CP002030), and 
Clostridium spp. (GQ240298). The tet(S) gene fragment, approximately 700 bp, detected in the 
E. gallinarum type strain showed a sequence identity of 99% with those of E. faecalis (GenBank 
accession No. JN208881, AM039489, and AM039490), E. faecium (GQ900487), Streptococcus 
spp. (KX077886, NG048275, and NG048276), and Listeria monocytogenes (NG048273 and 
JX865374). The transposon integrase gene was not detected in the 2 E. gallinarum isolates or in 
the E. gallinarum type strain possessing the TE-resistant gene.
DISCUSSION
In this study, the resistance levels to antibiotics other than glycopeptides were determined 
in detail for 24 Enterococcus strains that had been isolated from commercially available mouse 
strains showing intrinsic resistance to vancomycin as reported previously [12]. The results 
in the present study showed resistance to macrolides, fluoroquinolones, and TEs in 5 of the 
24 isolates. In addition, the mechanisms of resistance to each antibiotic agent in those 5 
isolates were investigated and the TE-resistant gene, tet(O), was identified in each of the TE-
resistant isolates. No resistant genes to macrolides and fluoroquinolones were detected in the 
macrolide- and fluoroquinolone-resistant isolates. In each commercial breeding companies 
that provided mice used in this study, antibiotics had not been used to eliminate pathogens 
in their laboratory mice [12]. Our results show that antibiotic resistance was not consistently 
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observed among the mice obtained from the same breeding company. In addition, although 
the drug-resistant bacteria were detected in laboratory mice [8,9], the emergence of drug 
resistance in laboratory animals has shown no correlation with emergences in humans or 
livestock [6]. Therefore, these antibiotic-resistant genes may be possessed intrinsically in 
the Enterococcus isolates or maintained for generations among the microbiota, including 
enterococci, of the mouse strain.
Although a macrolide-resistant gene, ermB, has frequently been detected in macrolide-
resistant enterococci in livestock, erm genes, including ermA and ermC, have only been 
detected in isolates that were highly resistant to macrolides [22,23]. In this study, 1 isolate 
showed low-level resistance to E with a MIC of 8 μg/mL. In addition to the erm genes, no PCR 
fragment of other macrolide- or multidrug-resistant genes were obtained. The macrolide-
resistant isolate in this study also indicated apparent resistance to fluoroquinolones with a 
MIC of 32 μg/mL for CIP. Other known or unknown factors might be associated with both the 
macrolide and fluoroquinolone resistance in this isolate.
Three VRE isolates, including one showing resistance to E, indicated resistance to 
fluoroquinolones. The antimicrobial effects of quinolones are the result of inhibition of 2 
subunits of DNA gyrase (gyrA and gyrB) or of DNA topoisomerase IV (parC and parE) [24,25]. 
The fluoroquinolone resistance in gram-positive bacteria is associated with AA substitutions 
in the QRDR of gyrA and gyrB, and parC and parE [26]. However, no AA substitutions were 
detected in the QRDR of the 3 fluoroquinolone-resistant isolates when compared with 
those of sensitive isolates and each Enterococcus spp. type strain. In addition to the QRDR 
and multidrug-resistant genes, another fluoroquinolone-resistant factor has been identified 
among the PMQR genes [26]. However, no PCR fragments of the expected molecular size 
indicating PMQR and multidrug-resistant genes were detected in the 3 fluoroquinolone-
resistant isolates in this study. Since the novel mutations in the QRDR and mechanisms 
associated with quinolone resistance have been clarified [26], another known or unknown 
mechanism may be involved in the fluoroquinolone resistance of the Enterococcus isolates.
Ribosomal protection genes tet(O) and tet(S) were detected in the 2 E. gallinarum isolates and in 
the E. gallinarum type strain, respectively, indicating apparent resistance to TE. The tet(O) and 
tet(S) genes were not commonly detected in the other E. gallinarum isolates, and the resistant 
isolates were not detected in the other mouse strains obtained from the same breeding 
company. Although the Tn916-Tn1545 transposon family gene associated with transferable 
tet genes was not detected in the 2 isolates in this study, the tet(O) gene has been detected 
on conjugative plasmids and is transferable via plasmids in enterococci [27,28]. Therefore, 
Enterococcus isolates from laboratory mice may spread the tet(O) genes horizontally, either intra- 
or inter-species. On the other hand, although the tet(O) gene confers resistance to both 1st 
generation (TE) and 2nd generation (MI and DX) TEs [27], our 2 Enterococcus isolates possessing 
the tet(O) gene showed apparent resistance only to TE, with only intermediate resistance to MI 
and DX. The DNA sequence identities of the tet(O) genes detected in our 2 isolates were not a 
complete match to the deposited DNA sequences in GenBank; furthermore, the detection of 
mosaic TE resistance genes has been reported [29]. Therefore, the tet(O) genes detected in this 
study may be classified as members of a new class of resistance gene.
Antibiotics have been used to control specific bacterial pathogens in laboratory mice in 
the animal facilities of academic institutions but not in the mouse populations of breeding 
companies [10,11]. The use of antibiotics induces the proliferation of drug-resistant bacteria 
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in a mouse colony and those bacteria may be spread to the other colonies by the users or 
caretakers of the mice. The data presented in this study may remind researchers and animal 
facility managers of the need to consider the existence of antibiotic-resistant bacteria in a 
laboratory mouse colony when antibiotics are used in laboratory mice.
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